PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
[41]   TENIPOSIDE IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP [J].
MUSS, HB ;
BUNDY, BN ;
YAZIGI, R ;
YORDAN, E .
CANCER TREATMENT REPORTS, 1987, 71 (09) :873-874
[42]   Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group [J].
Schilder, RJ ;
Blessing, J ;
Cohn, DE .
GYNECOLOGIC ONCOLOGY, 2005, 96 (01) :103-107
[43]   Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study [J].
Monk, Bradley J. ;
Sill, Michael W. ;
Burger, Robert A. ;
Gray, Heidi J. ;
Buekers, Thomas E. ;
Roman, Lynda D. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) :1069-1074
[44]   PHASE-II TRIAL OF CISPLATIN AS 1ST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
HOMESLEY, H ;
CREASMAN, WT ;
SUTTON, G .
GYNECOLOGIC ONCOLOGY, 1989, 33 (01) :68-70
[45]   Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix - A gynecologic oncology group study [J].
Lincoln, S ;
Blessing, JA ;
McGehee, R ;
Lentz, SS .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01) :84-85
[46]   PHASE-II TRIAL OF PIPERAZINEDIONE IN PATIENTS WITH ADVANCED OR RECURRENT UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
HOMESLEY, HD ;
HACKER, N ;
CURRY, SL .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05) :350-352
[47]   PHASE-II TRIAL OF VINBLASTINE IN ADVANCED OVARIAN-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SUTTON, GP ;
BLESSING, JA ;
ADELSON, MD ;
HANJANI, P .
INVESTIGATIONAL NEW DRUGS, 1990, 8 (04) :377-379
[48]   A PHASE-II CLINICAL-TRIAL OF DIAZIQUONE (AZQ) IN THE TREATMENT OF PATIENTS WITH RECURRENT ADENOCARCINOMA AND ADENOSQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SLAYTON, RE ;
BLESSING, JA ;
RETTENMAIER, M ;
BALL, H .
INVESTIGATIONAL NEW DRUGS, 1989, 7 (04) :337-340
[49]   Topotecan in squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group [J].
Bookman, MA ;
Blessing, JA ;
Hanjani, P ;
Herzog, TJ ;
Andersen, WA .
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) :446-449
[50]   Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study [J].
Santin, A. ;
Patricia, G. ;
Sill, M. ;
McMeekin, D. ;
Leitao, M. ;
Brown, J. ;
Sutton, G. ;
Van Le, L. ;
Boardman, C. .
GYNECOLOGIC ONCOLOGY, 2011, 121 (01) :S18-S18
12345